Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice
- PMID: 20977585
- PMCID: PMC2997326
- DOI: 10.1111/j.1463-1326.2010.01308.x
Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice
Abstract
Aim: To investigate the impact of chronic ingestion of sebacic acid (SA), a 10-carbon medium-chain dicarboxylic acid, on glycaemic control in a mouse model of type 2 diabetes (T2D).
Methods: Three groups of 15 db/db mice were fed for 6 weeks either a chow diet (Ctrl) or a chow diet supplemented with 1.5 or 15% (SA(1.5%) and SA(15%) , respectively) energy from SA. Fasting glycaemia was measured once a week and HbA1c before and after supplementation. An oral glucose tolerance test (OGTT) was performed at the end of the supplementation. Gene expression was determined by transcriptomic analysis on the liver of the Ctrl and SA(15%) groups.
Results: After 42 days of supplementation, fasting glycaemia and HbA1c were ∼70 and 25% lower in the SA(15%) group compared with the other groups showing a beneficial effect of SA on hyperglycaemia. During OGTT, plasma glucose area under the curve was reduced after SA(15%) compared with the other groups. This effect was associated with a tendency for an improved insulin response. In the liver, Pck1 and FBP mRNA were statistically decreased in the SA(15%) compared with Ctrl suggesting a reduced hepatic glucose output induced by SA.
Conclusion: Dietary supplementation of SA largely improves glycaemic control in a mouse model of T2D. This beneficial effect may be due to (i) an improved glucose-induced insulin secretion and (ii) a reduced hepatic glucose output.
© 2010 Blackwell Publishing Ltd.
Figures


Similar articles
-
Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.J Diabetes Res. 2014;2014:961732. doi: 10.1155/2014/961732. Epub 2014 Dec 24. J Diabetes Res. 2014. PMID: 25610880 Free PMC article.
-
Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice.Diabetes. 1999 Mar;48(3):588-94. doi: 10.2337/diabetes.48.3.588. Diabetes. 1999. PMID: 10078561
-
Effect of oral sebacic Acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes.Diabetes Care. 2010 Nov;33(11):2327-32. doi: 10.2337/dc10-0663. Epub 2010 Aug 19. Diabetes Care. 2010. PMID: 20724647 Free PMC article. Clinical Trial.
-
Use of dicarboxylic acids in type 2 diabetes.Br J Clin Pharmacol. 2013 Mar;75(3):671-6. doi: 10.1111/j.1365-2125.2012.04177.x. Br J Clin Pharmacol. 2013. PMID: 22242741 Free PMC article. Review.
-
Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Int J Clin Pract Suppl. 2002. PMID: 12166607 Review.
Cited by
-
Effectiveness of royal jelly supplementation in glycemic regulation: A systematic review.World J Diabetes. 2019 Feb 15;10(2):96-113. doi: 10.4239/wjd.v10.i2.96. World J Diabetes. 2019. PMID: 30788047 Free PMC article.
-
Optimization of Controlled-Release Microspheres Containing Vitexin and Isovitexin Through Experimental Design and Evaluation of Their Hypoglycemic Effects.Pharmaceutics. 2025 Jun 24;17(7):819. doi: 10.3390/pharmaceutics17070819. Pharmaceutics. 2025. PMID: 40733028 Free PMC article.
-
Transcriptomics Curation of SARS-CoV-2 Related Host Genes in Mice With COVID-19 Comorbidity: A Pilot Study.Infect Microbes Dis. 2020 May 6;2(2):42-47. doi: 10.1097/IM9.0000000000000025. eCollection 2020 Jun. Infect Microbes Dis. 2020. PMID: 38630104 Free PMC article.
-
The biochemistry and physiology of long-chain dicarboxylic acid metabolism.Biochem J. 2023 May 15;480(9):607-627. doi: 10.1042/BCJ20230041. Biochem J. 2023. PMID: 37140888 Free PMC article. Review.
-
Dicarboxylic acids counteract the metabolic effects of a Western diet by boosting energy expenditure.J Clin Invest. 2024 Jun 17;134(12):e181978. doi: 10.1172/JCI181978. J Clin Invest. 2024. PMID: 38959440 Free PMC article.
References
-
- Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2001;280:E23–30. - PubMed
-
- Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 1989;38:550–557. - PubMed
-
- DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194. - PubMed
-
- DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism. 1989;38:387–395. - PubMed
-
- Cerdan S, Künnecke B, Dölle A, Seelig J. In situ metabolism of 1, omega medium chain dicarboxylic acids in the liver of intact rats as detected by 13C and 1H NMR. J Biol Chem. 1988;263:11664–11674. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous